REVIEWRepurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions
Under a Creative Commons license
open access
Graphical abstract
Repurposing non-oncology drugs have been used to improve cancer therapy with the processes of target identification, in vitro and in vivo experiments, and clinical trials from the current situation to future directions.
Key words
Drug repurposing
Non-oncology drug
Cancer therapy
Cardiovascular drug
Microbiological drug
Small-molecule antibiotics
Anti-viral drug
Anti-inflammatory drug
Cited by (0)
Peer review under responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.
- †
These authors made equal contributions to this work.
© 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.